Clinical Scorecard: Comprehensive Transcriptomic Analysis of Rectal and Adipose Tissue HIV-1 Reservoirs Compared to Matched PBMCs in Individuals Under Antiretroviral Therapy
At a Glance
Category
Detail
Condition
HIV-1 persistence
Key Mechanisms
Viral sequestration in anatomical reservoirs, distinct immune environments in rectal and adipose tissues
Target Population
Individuals on antiretroviral therapy (ART)
Care Setting
Clinical research on HIV-1 reservoirs
Key Highlights
Higher HIV-1 DNA loads found in rectal and adipose tissues compared to PBMCs
Distinct host transcriptomic responses observed in rectal and adipose tissues
PI3K-Akt signaling pathway identified as a common feature across tissues
Fibrosis-associated gene COL1A1 and leukocyte marker CX3CR1 show tissue-specific expression
Study emphasizes the need to target anatomical sanctuaries beyond peripheral blood
Guideline-Based Recommendations
Diagnosis
Utilize ddPCR for quantifying HIV-1 DNA reservoirs in various tissues
Management
Consider the role of rectal and adipose tissues in HIV-1 persistence when developing treatment strategies
Monitoring & Follow-up
Monitor viral loads in non-blood tissues to assess treatment efficacy
Risks
Chronic mucosal inflammation and intestinal permeability may drive systemic immune activation
Patient & Prescribing Data
Individuals with HIV-1 on long-term ART
Adipose tissue may serve as a unique sanctuary for HIV-1, influencing treatment approaches
Clinical Best Practices
Integrate tissue-specific analyses in HIV-1 research
Focus on the immunometabolic environment of adipose tissue in HIV-1 persistence studies
Utilize comprehensive transcriptomic profiling to identify potential therapeutic targets
